P2X4 promotes interleukin-1β production in osteoarthritis via NLRP1

Molecular Medicine Reports

Volumn 9, Issue 1, 2014, Pages 340-344

  Fan, Changchun ^a   Zhao, Xuechun ^b   Guo, Xiaofan ^c   Cao, Xuecheng ^a   Cai, Jinfang ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

^b Third Hospital of Jinan   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Fibroblast like synoviocytes; Interleukin 1 ; NLRP1; Osteoarthritis; P2X4

Indexed keywords

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; APOPTOSIS REGULATORY PROTEINS; CELLS, CULTURED; FEMALE; HUMANS; INTERLEUKIN-1BETA; MALE; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; OSTEOARTHRITIS; RECEPTORS, PURINERGIC P2X4; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SYNOVIAL MEMBRANE;

EID: 84893854507     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1748     Document Type: Article

References (25)

1. Peat G, McCarney R and Croft P: Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care. Ann Rheum Dis 60: 91-97, 2011.
2. Clouet J, Vinatier C, Merceron C, Pot-vaucel M, Maugars Y, Weiss P, Grimandi G and Guicheux J: From osteoarthritis treatments to future regenerative therapies for cartilage. Drug Discov Today 14: 913-925, 2009.
3. Wright AA, Cook C and Abbott JH: Variables associated with the progression of hip osteoarthritis: a systematic review. Arthritis Rheum 61: 925-936, 2009.
4. Pap T, Müller-Ladner U, Gay RE and Gay S: Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res 2: 361-367, 2000.
5. Mor A, Abramson SB and Pillinger MH: The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin Immunol 115: 118-128, 2005.
6. Dinarello CA: A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur J Immunol 41: 1203-1217, 2011.
7. Jotanovic Z, Mihelic R, Sestan B and Dembic Z: Role of interleukin-1 inhibitors in osteoarthritis: an evidence-based review. Drugs Aging 29: 343-358, 2012.
8. Bauernfeind F, Ablasser A, Bartok E, Kim S, Schmid-Burgk J, Cavlar T and Hornung V: Inflammasomes: current understanding and open questions. Cell Mol Life Sci 68: 765-783, 2011.
9. Martinon F, Burns K and Tschopp J: The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10: 417-426, 2002.
10. Ray K: Crystal arthritis: NLRP3 inflammasome mediates crystal-induced joint inflammation and dysfunction. Nat Rev Rheumatol 7: 684, 2011.
11. Mathews RJ, Robinson JI, Battellino M, Wong C; Taylor JC; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS)
12. Eyre S, Churchman SM, Wilson AG, Isaacs JD, et al: Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Ann Rheum Dis: Aug 16, 2013 (Epub ahead of print).
13. Sakaki H, Fujiwaki T, Tsukimoto M, Kawano A, Harada H and Kojima S: P2X4 receptor regulates P2X7 receptor-dependent IL-1β and IL-18 release in mouse bone marrow-derived dendritic cells. Biochem Biophys Res Commun 432: 406-411, 2013.
14. Uzan B, Ea HK, Launay JM, Garel JM, Champy R, Cressent M and Lioté F: A critical role for adrenomedullin-calcitonin receptor-like receptor in regulating rheumatoid fibroblast-like synoviocyte apoptosis. J Immunol 176: 5548-5558, 2006.
15. Lioté F, Champy R, Moenner M, Boval-Boizard B and Badet J: Elevated angiogenin levels in synovial fluid from patients with inflammatory arthritis and secretion of angiogenin by cultured synovial fibroblasts. Clin Exp Immunol 132: 163-168, 2003.
16. Alqallaf SM, Evans BA and Kidd EJ: Atypical P2X receptor pharmacology in two human osteoblast-like cell lines. Br J Pharmacol 156: 1124-1135, 2009.
17. Klein K, Aeschlimann A, Jordan S, Gay R, Gay S and Sprott H: ATP induced brain-derived neurotrophic factor expression and release from osteoarthritis synovial fibroblasts is mediated by purinergic receptor P2X4. PLoS One 7: e36693, 2012.
18. Ulmann L, Hirbec H and Rassendren F: P2X4 receptors mediate PGE2 release by tissue-resident macrophages and initiate inflammatory pain. EMBO J 29: 2290-2300, 2010.
19. Troeberg L and Nagase H: Proteases involved in cartilage matrix degradation in osteoarthritis. Biochim Biophys Acta 1824: 133-145, 2012.
20. Li H, Li L, Min J, Yang H, Xu X, Yuan Y and Wang D: Levels of metalloproteinase (MMP-3, MMP-9), NF-kappaB ligand (RANKL), and nitric oxide (NO) in peripheral blood of osteoarthritis (OA) patients. Clin Lab 58: 755-762, 2012.
21. Levandowski CB, Mailloux CM, Ferrara TM, Gowan K, Ben S, Jin Y, McFann KK, Holland PJ, Fain PR, Dinarello CA and Spritz RA: NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome. Proc Natl Acad Sci USA 110: 2952-2956, 2013.
22. van de Veerdonk FL, Netea MG, Dinarello CA and Joosten LA: Inflammasome activation and IL-1β and IL-18 processing during infection. Trends Immunol 32: 110-116, 2011.
23. Masters SL, Gerlic M, Metcalf D, Preston S, Pellegrini M, O'Donnell JA, McArthur K, Baldwin TM, Chevrier S, Nowell CJ, et al: NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells. Immunity 37: 1009-1023, 2012.
24. Pontillo A, Girardelli M, Kamada AJ, Pancotto JA, Donadi EA, Crovella S and Sandrin-Garcia P: Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus. Autoimmunity 45: 271-278, 2012.
25. Sui J, Li H, Fang Y, Liu Y, Li M, Zhong B, Yang F, Zou Q and Wu Y: NLRP1 gene polymorphism influences gene transcription and is a risk factor for rheumatoid arthritis in han chinese. Arthritis Rheum 64: 647-654, 2012.